Two Different Buprenorphine Treatment Settings With Similar Retention Rates: Implications for Expanding Access to Treatment for Opioid Use Disorder

被引:0
|
作者
Tierney, Matthew [1 ]
Melino, Katerina [1 ]
Adeniji, Adebowale [2 ]
Shumway, Martha [1 ,3 ]
Allen, Isabel E. [1 ]
Waters, Catherine M. [1 ]
机构
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Community Mental Hlth Nurse, Daly City, CA USA
[3] Zuckerberg San Francisco Gen Hosp, San Francisco, CA USA
基金
美国国家卫生研究院;
关键词
buprenorphine; opioid-related disorders; health services accessibility; public health; retrospective studies; DRUG-ABUSE TREATMENT; MAINTENANCE THERAPY; PRIMARY-CARE; PUBLIC-HEALTH; METHADONE; PREDICTORS; DEPENDENCE; ADDICTION; NALOXONE; OUTCOMES;
D O I
10.1177/1078390318805562
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
INTRODUCTION: There is considerable need for effective and accessible treatment for opioid use disorder. AIMS: Our study explored differences in buprenorphine treatment retention and duration, with a focus on selected sociodemographic factors and treatment indicators, in two different settings: an office-based buprenorphine induction and stabilization clinic (OBIC) and a community-based primary care clinic (CPC). METHOD: This nonexperimental retrospective chart review compared demographic information and buprenorphine treatment details, including treatment retention and duration. RESULTS: There were no statistically significant differences in buprenorphine treatment indicators between the OBIC and CPC groups, with two exceptions: the number of written buprenorphine prescriptions was significantly greater for the OBIC group, as was the number of filled buprenorphine prescriptions. CONCLUSIONS: Given similar treatment retention and duration in two different buprenorphine treatment settings, our findings suggest that access to buprenorphine treatment in standard integrated care settings can be supplemented by novel treatment structures such as the OBIC in order to increase access to care during the current opioid epidemic.
引用
收藏
页码:305 / 313
页数:9
相关论文
共 50 条
  • [1] Barriers and Facilitators to Expanding Buprenorphine Treatment for Opioid Use Disorder in Jail Settings
    Kelsch, Jordan
    McGladrey, Margaret
    Oser, Carrie
    Booty, Marisa
    Fanucchi, Laura
    Walsh, Sharon
    Lofwall, Michelle
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2024, 260
  • [2] MICRODOSE BUPRENORPHINE INDUCTION: EXPANDING TREATMENT ACCESS TO HOSPITALIZED PATIENTS WITH OPIOID USE DISORDER
    Button, Dana
    Hartley, Jennifer
    Robbins, Jonathan
    Levander, Ximena A.
    Englander, Honora
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (SUPPL 1) : S122 - S122
  • [3] Comparing Two Databases to Identify Access to Buprenorphine Treatment for Opioid Use Disorder
    Anyanwu, Precious
    Varisco, Tyler J.
    Wanat, Matthew A.
    Bapat, Shweta
    Claborn, Kasey
    Thornton, J. Douglas
    [J]. JOURNAL OF PAIN & PALLIATIVE CARE PHARMACOTHERAPY, 2022, 36 (02) : 103 - 111
  • [4] Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees
    Hammerslag, Lindsey R.
    Mack, Aimee
    Chandler, Redonna K.
    Fanucchi, Laura C.
    Feaster, Daniel J.
    Larochelle, Marc R.
    Lofwall, Michelle R.
    Nau, Michael
    Villani, Jennifer
    Walsh, Sharon L.
    Westgate, Philip M.
    Slavova, Svetla
    Talbert, Jeffery C.
    [J]. JAMA NETWORK OPEN, 2023, 6 (10)
  • [5] Psychotherapy and three-year retention in buprenorphine treatment for opioid use disorder
    Manhapra, Ajay
    Agbese, Edeanya
    Leslie, Douglas
    Rosenheck, Robert
    [J]. AMERICAN JOURNAL ON ADDICTIONS, 2018, 27 (04): : 277 - 278
  • [6] Buprenorphine Treatment for Opioid Use Disorder: An Overview
    Matisyahu Shulman
    Jonathan M. Wai
    Edward V. Nunes
    [J]. CNS Drugs, 2019, 33 : 567 - 580
  • [7] Adherence to Buprenorphine Treatment in Opioid Use Disorder
    Williams, Ted D.
    Sumner, Michael
    Dixit, Shailja
    Urbaniak, Dennis
    [J]. AMERICAN JOURNAL ON ADDICTIONS, 2022, 31 (04): : 278 - 278
  • [8] Buprenorphine Treatment for Opioid Use Disorder: An Overview
    Shulman, Matisyahu
    Wai, Jonathan M.
    Nunes, Edward V.
    [J]. CNS DRUGS, 2019, 33 (06) : 567 - 580
  • [9] Improving Access to Pediatric Opioid Use Disorder Treatment With Buprenorphine Waiver Training
    Bayner, Jessica
    Ignaszewski, Martha
    [J]. AMERICAN JOURNAL ON ADDICTIONS, 2021, 30 (03): : 240 - 241
  • [10] Injectable Buprenorphine: An Opportunity to Improve Treatment Access for Youth With Opioid Use Disorder
    Calihan, Jessica B.
    Bagley, Sarah M.
    [J]. JOURNAL OF ADOLESCENT HEALTH, 2024, 75 (01) : 13 - 14